{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T13:10:16Z","timestamp":1789996216312,"version":"4.0.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013342","name":"NIHR Imperial Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013342","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/X020258\/1"],"award-info":[{"award-number":["MR\/X020258\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["valuehealthregionalissues.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health Regional Issues"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.vhri.2026.101656","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T04:10:47Z","timestamp":1780546247000},"page":"101656","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Health-related Quality of Life in Patients With Chronic Hepatitis B and Liver-Related Complications in The Gambia"],"prefix":"10.1016","volume":"57","author":[{"given":"Yazan","family":"Haddadin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alpha","family":"Suso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohey","family":"Bangura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sulayman","family":"Bah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjeeta","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Sicuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maud","family":"Lemoine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gibril","family":"Ndow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shevanthi","family":"Nayagam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jainaba","family":"Barry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lamin","family":"Bojang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Hallett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"D\u2019Alessandro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vhri.2026.101656_bib1","series-title":"Global Hepatitis Report 2024: Action for Access in Low- and Middle-Income Countries","year":"2024"},{"issue":"2","key":"10.1016\/j.vhri.2026.101656_bib4","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","year":"2017","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.vhri.2026.101656_bib5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1186\/s12876-023-02952-8","article-title":"Clinical manifestation, staging and prognosis of hepatocellular carcinoma in Gambian patients","volume":"23","author":"Bittaye","year":"2023","journal-title":"BMC Gastroenterol"},{"issue":"9","key":"10.1016\/j.vhri.2026.101656_bib6","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/S2214-109X(23)00263-2","article-title":"Clinical characteristics and outcomes of patients with cirrhosis and hepatocellular carcinoma in The Gambia, west Africa: a prospective cohort study","volume":"11","author":"Ndow","year":"2023","journal-title":"Lancet Glob Health"},{"issue":"4","key":"10.1016\/j.vhri.2026.101656_bib7","article-title":"Quality of life in patients with HBV infection: a systematic review and meta-analysis","volume":"7","author":"Fu","year":"2025","journal-title":"JHEP Rep"},{"issue":"1","key":"10.1016\/j.vhri.2026.101656_bib8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/1477-7525-12-101","article-title":"Significant impairment of health-related quality of life in mainland Chinese patients with chronic hepatitis B: a cross-sectional survey with pair-matched healthy controls","volume":"12","author":"Zhuang","year":"2014","journal-title":"Health Qual Life Outcomes"},{"issue":"3","key":"10.1016\/j.vhri.2026.101656_bib9","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1524-4733.2007.00297.x","article-title":"The impact of chronic hepatitis B on quality of life: a multinational study of utilities from infected and uninfected persons","volume":"11","author":"Levy","year":"2008","journal-title":"Value Health"},{"key":"10.1016\/j.vhri.2026.101656_bib10","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2147\/PROM.S226936","article-title":"Impact of stigma on people living with chronic hepatitis B","volume":"11","author":"Smith-Palmer","year":"2020","journal-title":"Patient Relat Outcome Meas"},{"issue":"6","key":"10.1016\/j.vhri.2026.101656_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-025503","article-title":"Chronic hepatitis B stigma in Ghana: a qualitative study with patients and providers","volume":"9","author":"Adjei","year":"2019","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.vhri.2026.101656_bib12","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-025415","article-title":"Screening, diagnosis and care cascade for viral hepatitis B and C in Yaound\u00e9, Cameroon: a qualitative study of patients and health providers coping with uncertainty and unbearable costs","volume":"9","author":"Chabrol","year":"2019","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.vhri.2026.101656_bib13","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1017\/S0266462320000124","article-title":"Using QALYs versus DALYs to measure cost-effectiveness: how much does it matter?","volume":"36","author":"Feng","year":"2020","journal-title":"Int J Technol Assess Health Care"},{"issue":"8","key":"10.1016\/j.vhri.2026.101656_bib14","doi-asserted-by":"crossref","first-page":"e568","DOI":"10.1016\/S2214-109X(16)30101-2","article-title":"Cost-effectiveness of community-based screening and treatment for chronic hepatitis B in The Gambia: an economic modelling analysis","volume":"4","author":"Nayagam","year":"2016","journal-title":"Lancet Glob Health"},{"issue":"7","key":"10.1016\/j.vhri.2026.101656_bib15","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S2468-1253(23)00074-2","article-title":"Impact and cost-effectiveness of hepatitis B virus prophylaxis in pregnancy: a dynamic simulation modelling study","volume":"8","author":"Nayagam","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.vhri.2026.101656_bib16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12962-020-00219-7","article-title":"Introduction of birth dose of hepatitis B virus vaccine to the immunization program in Ethiopia: an economic evaluation","volume":"18","author":"Memirie","year":"2020","journal-title":"Cost Eff Resour Alloc"},{"issue":"33","key":"10.1016\/j.vhri.2026.101656_bib17","doi-asserted-by":"crossref","first-page":"4659","DOI":"10.1016\/j.vaccine.2021.06.059","article-title":"Cost-effectiveness of adding a birth dose of hepatitis B vaccine in the Dafra district of the Hauts-Bassins Region in Burkina Faso (N\u00e9oVac Study)","volume":"39","author":"Gosset","year":"2021","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vhri.2026.101656_bib18","doi-asserted-by":"crossref","first-page":"e559","DOI":"10.1016\/S2214-109X(16)30130-9","article-title":"Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study","volume":"4","author":"Lemoine","year":"2016","journal-title":"Lancet Glob Health"},{"issue":"12","key":"10.1016\/j.vhri.2026.101656_bib19","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S2468-1253(24)00226-7","article-title":"Clinical outcomes of untreated adults living with chronic hepatitis B in The Gambia: an analysis of data from the prospective PROLIFICA cohort study","volume":"9","author":"Ndow","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.vhri.2026.101656_bib21","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research Electronic Data Capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.vhri.2026.101656_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"issue":"8","key":"10.1016\/j.vhri.2026.101656_bib23","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1136\/gutjnl-2015-309260","article-title":"The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa","volume":"65","author":"Lemoine","year":"2016","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.vhri.2026.101656_bib24","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQol-a new facility for the measurement of health-related quality of life","volume":"16","year":"1990","journal-title":"Health Policy"},{"issue":"1","key":"10.1016\/j.vhri.2026.101656_bib25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1478-7954-1-11","article-title":"How do Zimbabweans value health states?","volume":"1","author":"Jelsma","year":"2003","journal-title":"Popul Health Metr"},{"issue":"3","key":"10.1016\/j.vhri.2026.101656_bib26","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1177\/1536867X1501500307","article-title":"Fitting adjusted limited dependent variable mixture models to EQ-5D","volume":"15","author":"Alava","year":"2015","journal-title":"STATA J"},{"issue":"1","key":"10.1016\/j.vhri.2026.101656_bib27","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12939-017-0670-3","article-title":"Different indicators of socioeconomic status and their relative importance as determinants of health in old age","volume":"16","author":"Darin-Mattsson","year":"2017","journal-title":"Int J Equity Health"},{"key":"10.1016\/j.vhri.2026.101656_bib28","series-title":"The Gambia demographic and health survey 2019-20. Banjul, The Gambia and Rockville, USA: GBoS and ICF","year":"2021"},{"issue":"12","key":"10.1016\/j.vhri.2026.101656_bib30","doi-asserted-by":"crossref","first-page":"4765","DOI":"10.7314\/APJCP.2014.15.12.4765","article-title":"Dynamics and liver disease specific aspects of quality of life among patients with chronic liver disease in Yunnan, China","volume":"15","author":"Che","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"issue":"4","key":"10.1016\/j.vhri.2026.101656_bib31","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/hep.22138","article-title":"Health-related quality of life in chronic hepatitis B patients","volume":"47","author":"Ong","year":"2008","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.vhri.2026.101656_bib32","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1007\/s11136-014-0670-3","article-title":"Comparison between the EQ-5D-5L and the EQ-5D-3L in patients with hepatitis B","volume":"23","author":"Jia","year":"2014","journal-title":"Qual Life Res"},{"issue":"2","key":"10.1016\/j.vhri.2026.101656_bib33","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1177\/0269216314547103","article-title":"The prevalence and burden of symptoms in patients with chronic liver diseases in The Gambia, West Africa","volume":"29","author":"Shimakawa","year":"2015","journal-title":"Palliat Med"},{"issue":"5","key":"10.1016\/j.vhri.2026.101656_bib34","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.jhep.2023.06.018","article-title":"Palliative clinical trials in advanced chronic liver disease: challenges and opportunities","volume":"79","author":"Verma","year":"2023","journal-title":"J Hepatol"},{"issue":"9","key":"10.1016\/j.vhri.2026.101656_bib35","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-047475","article-title":"Assessing health-related quality of life and health utilities in patients with chronic hepatitis B-related diseases in China: a cross-sectional study","volume":"11","author":"Zhang","year":"2021","journal-title":"BMJ Open"},{"issue":"9","key":"10.1016\/j.vhri.2026.101656_bib36","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1177\/0269216318785830","article-title":"Assessing the validity of proxy caregiver reporting for potential palliative care outcome measures in Parkinson\u2019s disease","volume":"32","author":"Sebring","year":"2018","journal-title":"Palliat Med"},{"issue":"3","key":"10.1016\/j.vhri.2026.101656_bib37","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s40273-021-01101-x","article-title":"Developing the EQ-5D-5L value set for Uganda using the \u2018lite\u2019 protocol","volume":"40","author":"Yang","year":"2022","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.vhri.2026.101656_bib38","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.vhri.2019.08.475","article-title":"Valuing health state: an EQ-5D-5L value set for Ethiopians","volume":"22","author":"Welie","year":"2020","journal-title":"Value Health Reg Issues"},{"key":"10.1016\/j.vhri.2026.101656_bib39","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.puhe.2015.03.015","article-title":"Financial burden on the families of patients with hepatitis B virus-related liver diseases and the role of public health insurance in Yunnan Province of China","volume":"130","author":"Che","year":"2016","journal-title":"Public Health"},{"issue":"2","key":"10.1016\/j.vhri.2026.101656_bib40","doi-asserted-by":"crossref","first-page":"23","DOI":"10.9734\/ajmah\/2024\/v22i2980","article-title":"Catastrophic health expenditure and impoverishment amongst hepatitis B patients in a resource-poor setting","volume":"22","author":"Alali","year":"2024","journal-title":"Asian J Med Health"},{"issue":"11","key":"10.1016\/j.vhri.2026.101656_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004764","article-title":"Financial risk protection from vaccines in 52 Gavi-eligible low- and middle-income countries: a modeling study","volume":"22","author":"Jiao","year":"2025","journal-title":"PLOS Med"},{"issue":"8","key":"10.1016\/j.vhri.2026.101656_bib42","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.1478-3231.2007.01558.x","article-title":"Health-related quality of life in patients with chronic hepatitis B","volume":"27","author":"Bondini","year":"2007","journal-title":"Liver Int"},{"issue":"4","key":"10.1016\/j.vhri.2026.101656_bib43","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/jvh.13800","article-title":"Clinical and patient-reported outcome profile of patients with hepatitis B viral infection from the Global Liver Registry\u2122","volume":"30","author":"Younossi","year":"2023","journal-title":"J Viral Hepat"},{"issue":"11","key":"10.1016\/j.vhri.2026.101656_bib44","doi-asserted-by":"crossref","first-page":"e1133","DOI":"10.1016\/S2214-109X(17)30367-4","article-title":"Differences in health-related quality of life between HIV-positive and HIV-negative people in Zambia and South Africa: a cross-sectional baseline survey of the HPTN 071 (PopART) trial","volume":"5","author":"Thomas","year":"2017","journal-title":"Lancet Glob Health"},{"issue":"1","key":"10.1016\/j.vhri.2026.101656_bib45","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12955-024-02246-x","article-title":"The feasibility, repeatability, validity and responsiveness of the EQ-5D-3L in Krio for patients with stroke in Sierra Leone","volume":"22","author":"Youkee","year":"2024","journal-title":"Health Qual Life Outcomes"},{"issue":"2","key":"10.1016\/j.vhri.2026.101656_bib46","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1001\/jamacardio.2023.4553","article-title":"Optimization of evidence-based heart failure medications after an acute heart failure admission: a secondary analysis of the STRONG-HF randomized clinical trial","volume":"9","author":"Cotter","year":"2024","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.vhri.2026.101656_bib47","article-title":"An EQ-5D-5L value set for Ghana using an adapted EuroQol valuation technology protocol","volume":"45","author":"Addo","year":"2025","journal-title":"Value Health Reg Issues"},{"issue":"1","key":"10.1016\/j.vhri.2026.101656_bib48","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41467-022-35729-w","article-title":"Systematic review and individual-patient-data meta-analysis of non-invasive fibrosis markers for chronic hepatitis B in Africa","volume":"14","author":"Johannessen","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.vhri.2026.101656_bib49","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejim.2019.09.004","article-title":"Health-related quality of life in patients with compensated and decompensated liver cirrhosis","volume":"70","author":"Labenz","year":"2019","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.vhri.2026.101656_bib50","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2147\/PPA.S127139","article-title":"Health-related quality of life in patients with chronic hepatitis B during antiviral treatment and off-treatment","volume":"11","author":"Xue","year":"2017","journal-title":"Patient Prefer Adherence"},{"issue":"1","key":"10.1016\/j.vhri.2026.101656_bib51","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1186\/1756-0500-5-446","article-title":"Frequency of poor quality of life and predictors of health related quality of life in cirrhosis at a tertiary care hospital Pakistan","volume":"5","author":"Parkash","year":"2012","journal-title":"BMC Res Notes"},{"issue":"45","key":"10.1016\/j.vhri.2026.101656_bib52","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000035425","article-title":"Clinical and individual factors of quality of life of chronic liver disease patients at University of Gondar comprehensive specialized hospital, Northwest Ethiopia 2022","volume":"102","author":"Teshome","year":"2023","journal-title":"Medicine (Baltimore)"}],"container-title":["Value in Health Regional Issues"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109926000713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109926000713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:42:13Z","timestamp":1789994533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212109926000713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":48,"alternative-id":["S2212109926000713"],"URL":"https:\/\/doi.org\/10.1016\/j.vhri.2026.101656","relation":{},"ISSN":["2212-1099"],"issn-type":[{"value":"2212-1099","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Health-related Quality of Life in Patients With Chronic Hepatitis B and Liver-Related Complications in The Gambia","name":"articletitle","label":"Article Title"},{"value":"Value in Health Regional Issues","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vhri.2026.101656","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of International Society for Pharmacoeconomics and Outcomes Research, Inc.","name":"copyright","label":"Copyright"}],"article-number":"101656"}}